Healthpeak Properties, Inc. (DOC)
| Market Cap | 14.23B +16.8% |
| Revenue (ttm) | 3.06B +9.4% |
| Net Income | 377.12M |
| EPS | 0.54 |
| Shares Out | 702.54M |
| PE Ratio | 37.44 |
| Forward PE | 93.67 |
| Dividend | $1.22 (6.02%) |
| Ex-Dividend Date | Nov 13, 2026 |
| Volume | 5,995,425 |
| Open | 19.86 |
| Previous Close | 20.12 |
| Day's Range | 19.75 - 20.32 |
| 52-Week Range | 15.70 - 22.95 |
| Beta | 0.98 |
| Analysts | Buy |
| Price Target | 22.39 (+10.51%) |
| Earnings Date | Nov 2, 2026 |
About DOC
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery. Healthpeak Properties, Inc. is based in Denver, Colorado. Healthpeak Properties, Inc. was incorporated in 1985 in Maryland.
Financial Performance
In 2025, Healthpeak Properties's revenue was $2.82 billion, an increase of 4.52% compared to the previous year's $2.70 billion. Earnings were $70.51 million, a decrease of -70.91%.
Financial StatementsAnalyst Summary
According to 22 analysts, the average rating for DOC stock is "Buy." The 12-month stock price target is $22.39, which is an increase of 10.51% from the latest price.
News
Healthpeak Properties price target lowered to $21 from $23 at Cantor Fitzgerald
Cantor Fitzgerald lowered the firm’s price target on Healthpeak Properties (DOC) to $21 from $23 and keeps a Neutral rating on the shares.
Healthpeak Properties Earnings Call Transcript: Q3 2026
Operating strength lifted adjusted FFO guidance for a third time, while outpatient and senior housing growth remained robust. Life science occupancy gains and acquisitions position the portfolio for future NOI growth, balanced against higher refinancing costs and delayed lease commencements.
Healthpeak Properties Earnings release: Q3 2026
Healthpeak Properties released its Q3 2026 earnings on November 3, 2026, summarizing the period's financial results.
Healthpeak Properties Quarterly report: Q3 2026
Healthpeak Properties has published its Q3 2026 quarterly earnings report on November 3, 2026.
Healthpeak Properties reports Q3 AFFO 44c, consensus 43c
Reports Q3 revenue $820.892M, consensus $743.51M.
Healthpeak Properties raises FY26 AFFO view to $1.76-$1.78 from $1.73-$1.77
Consensus $1.77
Healthpeak Properties Reports Third Quarter 2026 Results and Increases Full Year 2026 Earnings Guidance
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) ("Healthpeak"), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announced results ...
Healthpeak Properties Slides: Transaction update presentation
Healthpeak Properties has posted slides in relation to its latest quarterly earnings report, which was published on November 2, 2026.
Healthpeak Properties price target lowered to $19 from $22 at Wells Fargo
Wells Fargo analyst John Kilichowski lowered the firm’s price target on Healthpeak Properties (DOC) to $19 from $22 and keeps an Equal Weight rating on the shares. Discussing earnings for…
Healthpeak Properties price target lowered to $20 from $21.50 at UBS
UBS lowered the firm’s price target on Healthpeak Properties (DOC) to $20 from $21.50 and keeps a Neutral rating on the shares.
Healthpeak Properties price target lowered to $21 from $24 at Barclays
Barclays analyst Richard Hightower lowered the firm’s price target on Healthpeak Properties (DOC) to $21 from $24 and keeps an Equal Weight rating on the shares. The firm adjusted targets…
Healthpeak Properties Announces Dates of Third Quarter 2026 Earnings Release, Conference Call, and Webcast
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, is scheduled to report third quarter 20...
Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the Fourth Quarter of 2026
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) ("Healthpeak"), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced that on Octobe...
With REIT, Investors Don't Have to Write Off REITs
The 10- and 30-year Treasury is ominously elevated. And the Federal Reserve is fresh off one interest rate hike and potentially heading for another before the end of the year.
Healthpeak Properties price target lowered to $22 from $23 at Evercore ISI
Evercore ISI analyst James Kammert lowered the firm’s price target on Healthpeak Properties (DOC) to $22 from $23 and keeps an In Line rating on the shares. Adjustments to REIT…
Healthpeak Properties assumed with a Hold at Jefferies
Jefferies assumed coverage of Healthpeak Properties (DOC) with a Hold rating with a price target of $21, down from $22. The firm says senior housing remains its preferred way to…
Healthpeak Properties, Inc. (NYSE: DOC) President and CEO Scott Brinker Interviewed by Advisor Access
SAN FRANCISCO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Healthpeak Properties, Inc. (NYSE: DOC) is a fully integrated real estate investment trust (REIT) and S&P 500 company.
Healthpeak Properties price target raised to $24 from $23 at Barclays
Barclays raised the firm’s price target on Healthpeak Properties (DOC) to $24 from $23 and keeps an Equal Weight rating on the shares. The firm adjusted targets in the healthcare…
Healthpeak Properties price target raised to $25 from $24 at BofA
BofA analyst Farrell Granath raised the firm’s price target on Healthpeak Properties (DOC) to $25 from $24 and keeps a Buy rating on the shares. The firm updated its price…
Healthpeak Properties price target raised to $24 from $21 at Baird
Baird raised the firm’s price target on Healthpeak Properties (DOC) to $24 from $21 and keeps an Outperform rating on the shares. The firm updated its model following Q2 results…
Healthpeak Properties price target raised to $22 from $20 at Citi
Citi raised the firm’s price target on Healthpeak Properties (DOC) to $22 from $20 and keeps a Neutral rating on the shares.
Healthpeak Properties price target raised to $23 from $20 at Cantor Fitzgerald
Cantor Fitzgerald analyst Richard Anderson raised the firm’s price target on Healthpeak Properties (DOC) to $23 from $20 and keeps a Neutral rating on the shares.
Healthpeak Properties Earnings Call Transcript: Q2 2026
Q2 2026 saw strong leasing and occupancy gains across outpatient, lab, and senior housing, with FFO adjusted guidance raised and leverage below 5x. Major capital recycling and strategic partnerships, including a $1B Brookfield JV, strengthened the balance sheet.
Healthpeak Properties Earnings release: Q2 2026
Healthpeak Properties released its Q2 2026 earnings on August 5, 2026, summarizing the period's financial results.
Healthpeak Properties Quarterly report: Q2 2026
Healthpeak Properties has published its Q2 2026 quarterly earnings report on August 5, 2026.